Drug profile · INN
calcifediol
RAYALDEE
calcifediol (RAYALDEE) is a vitamin d receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — calcifediol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
calcifediol (RAYALDEE) is a vitamin d receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Vitamin D receptor agonist
Primary target: Vitamin D3 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is calcifediol?
calcifediol (RAYALDEE) is a vitamin d receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for calcifediol?
RAYALDEE is a marketed brand name for calcifediol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calcifediol?
calcifediol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.